Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

Gene Express, Inc. Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   25
ISBN Number   not applicable
Product Code   GMD644
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Gene Express, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - In Vitro Diagnostics
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Key Employees
  • 6 Key Employee Biographies
  • 7 Locations And Subsidiaries
    • 7.1 Head Office
  • 8 Recent Developments
    • 8.1 Corporate Communications
      • 8.1.1 Jun 12, 2008: Gene Express Appoints Senior Vice President, Global Marketing
      • 8.1.2 Mar 17, 2008: Gene Express Appoints SAB Member
      • 8.1.3 Jan 07, 2008: Gene Express Appoints SVP
    • 8.2 Other Significant Developments
      • 8.2.1 Apr 21, 2008: Gene Express Signs Agreement With USF To License Gene Expression Technology
  • 9 Gene Express, Inc. Pipeline Products
    • 9.1 Gene Express, Inc. Product Pipeline Analysis
      • 9.1.1 Gene Express, Inc. Pipeline Products By Equipment Type
      • 9.1.2 Gene Express, Inc. Pipeline Products By Development Stage
      • 9.1.3 Gene Express, Inc. Pipeline Products By Therapy Area
      • 9.1.4 Gene Express, Inc. Pipeline Products By Clinical Trials
    • 9.2 Blood Culture Measurement
      • 9.2.1 Product Description
      • 9.2.2 Product Status
    • 9.3 Molecular Diagnostic Tests For Lung Cancer
      • 9.3.1 Product Description
      • 9.3.2 Product Status
    • 9.4 Molecular Diagnostic Tests For Bladder Cancer
      • 9.4.1 Product Description
      • 9.4.2 Product Status
    • 9.5 Whole Blood Analysis
      • 9.5.1 Product Description
      • 9.5.2 Product Status
      • 9.5.3 Clinical Trials
    • 9.6 New StaRT-PCR Assays
      • 9.6.1 Product Description
      • 9.6.2 Product Status
  • 10 Appendix
    • 10.1 Methodology
      • 10.1.1 Coverage
      • 10.1.2 Secondary Research
      • 10.1.3 Primary Research
      • 10.1.4 Expert Panel Validation
    • 10.2 Contact Us
    • 10.3 About Global Markets Direct
    • 10.4 Disclaimer
  • 1 List of Tables
    • Table 1: Gene Express, Inc.,Key Facts
    • Table 2: Gene Express, Inc., Key Employees,
    • Table 3: Gene Express, Inc. Pipeline Products by Equipment Type
    • Table 4: Gene Express, Inc. Pipeline Products By Development Stage
    • Table 5: Gene Express, Inc. Pipeline Products By Therapy Area
    • Table 6: Gene Express, Inc. Pipeline Products By Clinical Trials
    • 1.2 List of Figures
    • Figure 1: Gene Express, Inc. Pipeline Products By Equipment Type
    • Figure 2: Gene Express, Inc. Pipeline Products By Equipment Type
    • Figure 3: Gene Express, Inc. Pipeline Products By Development Stage
    • Figure 4: Global Markets Direct Methodology